Category of chemicals: Inhibitor drug

Products of Inhibitor drug
CAS No.	Product Name	Molecular Formula
101536-55-4	Neurokinin B	C₅₅H₇₉N₁₃O₁₄S₂
1038915-60-4	Niraparib	C₁₉H₂₀N₄O
1068148-47-9	BIBP 3226 trifluoroacetate	C₂₉H₃₂F₃N₅O₅
1078-21-3	4-Amino-3-phenylbutyric acid hydrochloride	C₁₀H₁₄ClNO₂
109844-92-0	N-(4-chlorophenyl)-5-nitrofuran-2-carboxamide	C₁₁H₇ClN₂O₄
1152782-19-8	A 1120	C₂₀H₁₉F₃N₂O₃
1197953-54-0	Brigatinib	C₂₉H₃₉ClN₇O₂P
123690-79-9	CGP-35348	C₈H₂₀NO₄P
1373764-75-0	2-(4-Hydroxyphenyl)-1-(1,3,4,9-tetrahydropyrido[3,4-b]indol-2-yl)ethanone	C₁₉H₁₈N₂O₂
142356-40-9	2-bromo-5,6-dichloro-1H-benzimidazole	C₇H₃BrCl₂N₂
1427001-89-5	AMY-101	C₈₃H₁₁₇N₂₃O₁₈S₂
1441190-66-4	Cyclic guanosine monophosphate-adenosine monophosphate	C₂₀H₂₄N₁₀O₁₃P₂
1443290-89-8	ML67-33	C₁₈H₁₇Cl₂N₅
157009-81-9	GPRP acetate	C₂₀H₃₅N₇O₇
162359-56-0	Fingolimod hydrochloride	C₁₉H₃₃NO₂.HCl
1627580-64-6	MOTS-C	C₁₀₁H₁₅₂N₂₈O₂₂S₂
1627929-55-8	PLX51107	C₂₆H₂₂N₄O₃
1673560-66-1	PD-1-IN-17	C₁₃H₂₂N₆O₇
168828-81-7	(3-Fluoro-4-morpholin-4-ylphenyl)carbamic acid benzyl ester	C₁₈H₁₉FN₂O₃
1818885-28-7	ARV-825	C₄₆H₄₇ClN₈O₉S
1821387-73-8	CU-T12-9	C₁₇H₁₃F₃N₄O₂
1834571-04-8	Tat-NR2B9c TFA	C₁₀₇H₁₈₉F₃N₄₂O₃₂
183905-31-9	(S)-1-[(Acetylamino)methyl]-2-chloroethyl acetate	C₇H₁₂ClNO₃
186139-09-3	MSI-1436	C₃₇H₇₂N₄O₅S
1903763-82-5	Sisunatovir	C₂₃H₂₂F₄N₄O
1992047-64-9	MS023 (dihydrochloride)	C₁₇H₂₇Cl₂N₃O
2040295-03-0	Pexidartinib Hydrochloride	C₂₀H₁₆Cl₂F₃N₅
2095886-80-7	4-(difluoromethyl)-L-leucine	C₇H₁₃F₂NO₂
210302-17-3	BAM15	C₁₆H₁₀F₂N₆O
2169919-21-3	Revumenib	C₃₂H₄₇FN₆O₄S
2170722-84-4	Emraclidine	C₂₀H₂₁F₃N₄O
2226517-76-4	Sgc-gak-1	C₁₈H₁₇BrN₂O₃
2259884-03-0	Mazdutide	C₂₀₇H₃₁₇N₄₅O₆₅
2332841-25-3	TBAJ-876	C₃₁H₃₇BrN₄O₇
2375421-09-1	SR-717 lithium	C₁₅H₈F₂LiN₅O₃
2381089-83-2	Retatrutide	C₂₂₁H₃₄₂N₄₆O₆₈
259870-32-1	2-phenyl-N-(pyridin-4-ylmethyl)quinazolin-4-amine	C₂₀H₁₆N₄
2603528-97-6	(2S,3R)-1-(3-Cyano-6-methyl-4-(trifluoromethyl)pyridin-2-yl)-3-hydroxy-N-methyl-N-(m-tolyl)pyrrolidine-2-carboxamide	C₂₁H₂₁F₃N₄O₂
263878-43-9	Nafarelin Acetate	C₆₈H₈₇N₁₇O₁₅
2761063-79-8	ELOVL1-IN-2	C₁₈H₁₅FN₂O
301177-43-5	ESI-08	C₂₀H₂₃N₃OS
303094-67-9	1-(4,6-dimethylpyrimidin-2-yl)-3-[2-(trifluoromethyl)phenyl]guanidine	C₁₄H₁₄F₃N₅
317318-70-0	GW 501516	C₂₁H₁₈F₃NO₃S₂
349106-80-5	2,2-dichloro-N-(3-chloro-4-fluorophenyl)acetamide	C₈H₅Cl₃FNO
359714-55-9	CAY10499	C₁₈H₁₇N₃O₅
363600-92-4	Tlr2-IN-C29	C₁₆H₁₅NO₄
37836-90-1	1-(7-Methoxy-4-methylquinazolin-2-yl)guanidine	C₁₁H₁₃N₅O
379270-37-8	Tenofovir alafenamide	C₂₁H₂₉N₆O₅P
400827-55-6	4-[2-[[(6R,7R)-2-Carboxy-7-[[(2Z)-(ethoxyimino)[5-(phosphonoamino)-1,2,4-thiadiazol-3-yl]acetyl]amino]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-en-3-yl]thio]-4-thiazolyl]-1-methylpyridinium acetate hydrate	C₂₂H₂₂N₈O₈PS₄.C₂H₃O₂.H₂O
439081-18-2	BIBW 2992	C₂₄H₂₅ClFN₅O₃
491839-65-7	WAY-320461	C₁₅H₁₀BrN₃O₂S
51833-76-2	Angiotensin 1/2 + A (2-8) Acetate	C₄₉H₇₁N₁₃O₁₀
606143-52-6	AZD 6244	C₁₇H₁₅BrClFN₄O₃
612514-42-8	3-amino-N-(1,3-benzodioxol-5-ylmethyl)-4,6-dimethylthieno[2,3-b]pyridine-2-carboxamide	C₁₈H₁₇N₃O₃S
654671-77-9	Sitagliptin phosphate monohydrate	C₁₆H₁₅F₆N₅O.H₃PO₄.H₂O
684234-60-4	2-(4-(4-Chlorophenyl)-1-oxophthalazin-2(1H)-yl)-N-(4-fluorophenyl)acetamide	C₂₂H₁₅ClFN₃O₂
827022-32-2	6-Acetyl-8-cyclopentyl-5-methyl-2-[[5-(1-piperazinyl)-2-pyridinyl]amino]pyrido[2,3-d]pyrimidin-7(8H)-one hydrochloride	C₂₄H₂₉N₇O₂.HCl
853400-76-7	Trofinetide	C₁₃H₂₁N₃O₆
857679-55-1	INCB 8761	C₂₉H₃₁F₃N₆O₃
877399-52-5	Crizotinib	C₂₁H₂₂Cl₂FN₅O
891016-02-7	ML-SI3	C₂₃H₃₁N₃O₃S
901599-43-7	N-(4-methoxyphenyl)quinoxaline-2-carboxamide	C₁₆H₁₃N₃O₂
914454-01-6	Exendin-4 (Acetate)	C₁₈₄H₂₈₂N₅₀O₆₀S .C₂H₄O₂
951441-04-6	Sephin1	C₈H₉ClN₄
99-52-5	2-Methyl-4-nitroaniline	C₇H₈N₂O₂

Category of Chemicals

Inhibitor drug

Inhibitors control specific biological processes, serving as crucial tools in research and therapeutic applications. They can target various pathways, making them versatile agents in healthcare and scientific investigations.